Quick Order Cart

Cat. No. ARG42588

CAT Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The CAT knockout HEK293T polyclonal cells are a CRISPR/Cas9-edited loss-of-function model disrupting the catalase gene. Derived from human embryonic kidney HEK293T cells, these polyclonal knockout cells are widely used for exploring redox biology and oxidative stress responses. Catalase is transcriptionally regulated by NFE2L2, FOXO3, and TP53, and functionally interacts with superoxide dismutase 1 (SOD1) and glutathione peroxidase to decompose hydrogen peroxide. Its knockout elevates intracellular H2O2, enabling applications in antioxidant screening, drug toxicity, aging, and cancer research using ROS measurement by DCFDA flow cytometry and cell viability assays under oxidative challenge.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    CAT

    Gene Identifier

    NCBI Gene ID 847

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CAT knockout HEK293T polyclonal cells are a CRISPR/Cas9-edited polyclonal population with targeted disruption of the catalase (CAT) gene. Generated in the widely used HEK293T background, this loss-of-function model enables investigation of catalase-dependent redox mechanisms. Its polyclonal nature ensures a heterogeneous allele mixture, allowing robust gene function assessment without clonal selection artifacts. This CRISPR/Cas9-mediated gene disruption tool is critical for exploring oxidative stress responses and hydrogen peroxide metabolism.

HEK293T cells, derived from human embryonic kidney and transformed with adenovirus 5 DNA, stably express SV40 large T antigen. This epithelial-like cell line is renowned for high transfectability, viral packaging, and recombinant protein production, making it an ideal host for knockout models. The robust proliferative capacity and genetic tractability of HEK293T provide a controlled environment for studying oxidative stress biology and downstream signaling pathways following CAT disruption.

Catalase is an essential antioxidant enzyme that decomposes hydrogen peroxide into water and oxygen, shielding cells from oxidative damage. Its transcription is activated by FOXO3 and NFE2L2 (Nrf2), with additional regulation by PPARG, TP53, and NF-??B. Functionally, catalase interacts with superoxide dismutase 1 (SOD1), glutathione peroxidase, and peroxiredoxins to detoxify reactive oxygen species. Downstream of the NFE2L2?CKEAP1 axis, catalase reduces H2O2 levels, thereby modulating MAPK signaling, NF-??B activity, and suppressing caspase-3/9-mediated apoptosis to maintain redox homeostasis.

CRISPR/Cas9-mediated knockout of CAT in HEK293T polyclonal cells abolishes catalase activity, causing intracellular hydrogen peroxide buildup and elevated basal oxidative stress. This sensitizes the cells to oxidative insults, enabling precise study of redox-sensitive pathways. In the context of actively proliferating HEK293T cells, the model reveals how catalase deficiency influences NF-??B and MAPK pathways. It thus provides a powerful system to explore the impact of oxidative stress on proliferation, survival, and metabolic adaptation.

These polyclonal knockout cells are ideal for antioxidant screening via DCFDA flow cytometry, drug toxicity assessment under H2O2 stress, and catalase validation by RT-qPCR or Western blotting. They also support research in aging, cancer biology, and metabolic disorders where catalase dysfunction is key. For further inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)